EP1409467A1 — Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
Assigned to Genzyme Corp · Expires 2004-04-21 · 22y expired
What this patent protects
Disclosed is a novel enantiomeric synthesis cermamide-like inhibitors of UDP-glucose: <i>N</i>-acylsphingosine glucosyltransferase. Also disclosed are novel intermediates formed during the synthesis.
USPTO Abstract
Disclosed is a novel enantiomeric synthesis cermamide-like inhibitors of UDP-glucose: <i>N</i>-acylsphingosine glucosyltransferase. Also disclosed are novel intermediates formed during the synthesis.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.